Obesity, hypertension, and cardiovascular health: Is there anything poor Cassandra tries to tell us?

Journal of Hypertension

Volumn 30, Issue 6, 2012, Pages 1103-1105

  Jordan, Jens ^a   Engeli, Stefan ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT;

ABDOMINAL OBESITY; ANTIHYPERTENSIVE ACTIVITY; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; FOLLOW UP; HEALTH; HUMAN; HYPERTENSION; JAPAN; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84861021900     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283542da0     Document Type: Note

References (22)

1. Tsujimoto T, Sairenchi T, Iso H, Irie F, Yamagishi K, Tanaka K, et al. Impact of obesity on incident hypertension independent of weight gain among nonhypertensive Japanese: The Ibaraki Prefectural Health Study (IPHS). J Hypertens 2012; 30:1122-1128.
2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-1645.
3. Nakamura K, Nanri H, Hara M, Higaki Y, Imaizumi T, Taguchi N, et al. Optimal cut-off values of waist circumference and the discriminatory performance of other anthropometric indices to detect the clustering of cardiovascular risk factors for metabolic syndrome in Japanese men and women. Environ Health Prev Med 2011; 16:52-60.
4. Oka R, Kobayashi J, Yagi K, Tanii H, Miyamoto S, Asano A, et al. Reassessment of the cut-off values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 2008; 79:474-481.
5. Jordan J, Yumuk V, Schlaich M, Nilsson PM, Zahorska-Markiewicz B, Grassi G, et al. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens 2012; 30:1047-1055.
6. Bramlage P, Pittrow D, Wittchen HU, Kirch W, Boehler S, Lehnert H, et al. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 2004; 17:904-910.
7. Bhan V, Yan RT, Leiter LA, Fitchett DH, Langer A, Lonn E, et al. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients. Am J Cardiol 2010; 106:1270-1276.
8. Lloyd-Jones DM, Evans JC, Larson MG, O'donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36:594-599.
9. Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 2011; 124:1046-1058.
10. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and allcause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J 2006; 27:107-113.
11. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980- 2000. N Engl J Med 2007; 356:2388-2398.
12. Bjorck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009; 30:1046-1056.
13. Bandosz P, O'Flaherty M, Drygas W, Rutkowski M, Koziarek J, Wyrzykowski B, et al. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ 2012; 344:d8136.
14. Ahern RM, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray CJ. Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr 2011; 9:8.
15. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005; 162:764-773.
16. Capewell S, Ford ES. Why have total cholesterol levels declined in most developed countrieš BMC Public Health 2011; 11:641.
17. Di AE, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302:1993-2000.
18. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005; 294:1773-1781.
19. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev 2012; 70:3-21.
20. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999- 2010. JAMA 2012; 307:483-490.
21. Yoshinaga M, Ichiki T, Tanaka Y, Hazeki D, Horigome H, Takahashi H, et al. Prevalence of childhood obesity from 1978 to 2007 in Japan. Pediatr Int 2010; 52:213-217.
22. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999- 2010. JAMA 2012; 307:491-497.